Stock listing

LS Exchange:A2N7L2 Twist Bioscience Corporation Aktie

German listing (LS Exchange) of Twist Bioscience Corporation · home listing NASDAQ:TWST

Follow Twist Bioscience Corporation into a list and get an email when it puts out news.

Home listing price · NASDAQ:TWST

$103.32 USD -13.03 (-11.2%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:TWST

Past year +296.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$101.00 – $108.50 USDNov 20, 2026
Volume
3.38M sharesNov 20, 2026
Market cap
$7.04B USDAt the close on Nov 20, 2026 · price × 68.18M shares outstanding
52-week range
$25.67 – $219.71 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$368.8M USDMedian day 2.11M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Twist Bioscience Corporation logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:TWST · Home$103.32 USD-13.03 (-11.2%)3,378,941$108.39$108.50$101.00$116.35Close on Nov 20, 2026
Frankfurt:0ME€108.25 EUR+6.00 (+5.9%)—€103.55€108.25€103.50€102.25Close on Nov 19, 2026
Stuttgart:0ME€93.62 EUR-18.58 (-16.6%)284€97.00€98.78€92.16€112.20Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:TWST · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$103.32-13.03-11.2%$108.39$108.50$101.003,378,941
$116.35+4.35+3.9%$112.17$119.81$109.972,225,481
$112.00+6.96+6.6%$106.51$112.24$102.822,064,837
$105.04-6.56-5.9%$106.00$106.28$101.052,571,116
$111.60-2.62-2.3%$110.50$114.42$106.812,046,248
$114.22-8.37-6.8%$99.59$114.93$93.855,300,593
$122.59-9.54-7.2%$141.00$151.50$122.083,471,551
$132.13-3.21-2.4%$133.00$138.06$125.581,718,909
$135.34+14.55+12.0%$124.17$138.24$121.241,669,346
$120.79+0.18+0.1%$123.83$130.90$116.502,055,221
$120.61-21.97-15.4%$134.79$134.98$118.603,084,091
$142.58+2.28+1.6%$140.78$142.97$131.321,877,181
$140.30+11.26+8.7%$130.35$141.62$130.221,937,136
$129.04-23.74-15.5%$153.17$154.11$128.512,671,309
$152.78-20.67-11.9%$161.39$167.27$148.003,397,719
$173.450.000.0%$170.21$177.69$169.071,754,381
$173.45+13.60+8.5%$160.44$178.53$159.033,478,536
$159.85+14.60+10.1%$145.74$162.57$143.701,755,504
$145.25+5.33+3.8%$139.45$147.62$136.191,379,313
$139.92+4.45+3.3%$132.95$140.74$131.231,857,400
$135.47-13.66-9.2%$143.50$150.14$131.852,689,700
$149.13+6.43+4.5%$139.34$153.80$138.252,634,400
$142.70+2.93+2.1%$139.77$148.83$134.942,019,000
$139.77+7.02+5.3%$136.99$141.80$133.721,592,400
$132.75-11.74-8.1%$143.88$145.05$130.982,826,600
$144.49-3.67-2.5%$138.09$148.32$130.683,542,600
$148.16-3.17-2.1%$146.69$156.00$144.792,114,700
$151.33-0.53-0.3%$149.00$154.23$146.001,529,100
$151.86-7.92-5.0%$159.78$161.80$147.552,650,200
$159.78+7.73+5.1%$152.69$168.93$152.143,540,000
$152.05-3.60-2.3%$148.00$152.59$144.604,371,500
$155.65-11.32-6.8%$158.26$167.44$152.505,897,500
$166.97-38.03-18.6%$209.55$219.71$164.498,557,500
$205.00+16.33+8.7%$193.46$207.90$189.253,205,000
$188.67+0.62+0.3%$188.76$198.10$183.392,081,400
$188.05-5.19-2.7%$193.10$200.31$187.603,115,500
$193.24+7.11+3.8%$188.75$197.19$187.053,251,000
$186.13+6.53+3.6%$179.90$190.76$179.733,680,200
$179.60-3.23-1.8%$181.82$187.87$175.022,196,800
$182.83-1.20-0.7%$184.03$186.20$177.392,706,200
$184.03+25.53+16.1%$157.72$185.22$156.833,529,400
$158.50-6.10-3.7%$164.35$166.35$157.412,133,700
$164.60-1.23-0.7%$165.83$170.66$162.862,313,700
$165.83-1.16-0.7%$168.40$170.23$160.622,239,300
$166.99+11.43+7.3%$158.04$167.05$156.163,071,500
$155.56+12.49+8.7%$151.43$163.70$150.003,369,400
$143.07+4.97+3.6%$142.28$148.50$137.082,406,600
$138.10+3.35+2.5%$134.04$138.93$131.541,287,900
$134.75+7.53+5.9%$126.04$136.86$121.921,806,100
$127.22+0.37+0.3%$127.92$130.00$125.881,108,600
$126.85+1.33+1.1%$121.66$129.28$120.191,285,000
$125.52-2.54-2.0%$126.51$130.99$122.521,835,000
$128.06+3.34+2.7%$121.38$131.60$120.711,805,500
$124.72-3.99-3.1%$125.19$128.13$123.75900,800
$128.71-2.29-1.7%$132.85$133.95$127.421,065,600
$131.00-1.06-0.8%$131.43$140.80$126.421,900,100
$132.06-6.94-5.0%$134.94$138.15$131.001,275,200
$139.00-2.38-1.7%$139.99$140.60$135.001,892,100
$141.38-11.72-7.7%$150.05$153.11$140.991,377,800
$153.10+3.04+2.0%$149.23$155.44$148.441,252,200
$150.06-1.36-0.9%$148.00$154.00$147.001,210,500
$151.42+10.62+7.5%$145.73$154.96$141.412,078,200
$140.80-4.79-3.3%$145.37$145.41$137.371,804,800
$145.59+9.26+6.8%$138.43$145.93$135.051,794,400
$136.33-6.06-4.3%$136.84$145.51$135.172,398,600
Ticker
LS Exchange:A2N7L2
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
LS Exchange
Currency
EUR

What changed lately

Latest news

All Twist Bioscience Corporation news

Twist Bioscience Corporation on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
25 in the last 12 months · 249 in all · newest Nov 12, 2026 · oldest 2019
Calls
23 calls with a replay · 23 with a transcript · latest Nov 12, 2026
Decks
16 decks · latest Nov 12, 2026

Where Twist Bioscience Corporation is listed

ListingExchangeCountryCurrency
NASDAQ:TWST · Home listingNASDAQUnited StatesUSD
gettex:0MEgettexGermanyEUR
Tradegate:0METradegateGermanyEUR
Milan:1TWSTMilanItalyEUR
BOATS:TWSTBOATSUnited StatesUSD
LS Exchange:A2N7L2 · This pageLS ExchangeGermanyEUR
Lang & Schwarz:A2N7L2Lang & SchwarzGermanyEUR
Frankfurt:0MEFrankfurtGermanyEUR
Dusseldorf:0MEDusseldorfGermanyEUR
Hamburg:0MEHamburgGermanyEUR
Munich:0MEMunichGermanyEUR
Stuttgart:0MEStuttgartGermanyEUR
BMV:TWSTBMVMexicoMXN
Hanover:0MEHanoverGermanyEUR
Xetra:0MEXetraGermanyEUR

Valuation

EV/sales 14.1× against a median of 6.9×: 10th lowest of 11 Diagnostics & research services companies shown. Statements: Year to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$6.46B USD
P/E
Loss
EV/sales
14.1×
EV/EBITDA
Negative EBITDA
Price/book
7.9×
Gross margin
52.4%
Operating margin
−30.3%
Net margin
−28.3%
Debt to equity
0.0×
Beta vs S&P 500
2.77

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Twist Bioscience Corporation · NASDAQ:TWSTUS$7.04BUS$6.46Bn/a14.1×n/a7.9×−28.3%0.0×2.77
Tempus AI, Inc. · NASDAQ:TEMUS$9.58BUS$8.99Bn/a6.0×n/a19.1×−12.5%0.0×2.51
Bruker Corporation · NASDAQ:BRKRUS$8.62BUS$10.22Bn/a2.9×64.4×3.7×−3.5%0.7×1.72
Pharmaron Beijing Co., Ltd. Class A · SZSE:300759US$8.52BUS$8.23B32.1×3.4×n/a3.4×11.1%0.1×n/a
GenScript Biotech Corporation · HKEX:1548US$8.08BUS$7.50Bn/a7.8×22.8×2.1×−55.5%0.1×n/a
Bio-Rad Laboratories, Inc. · NYSE:BIOUS$7.84BUS$7.38B7.7×2.8×71.0×1.0×39.5%0.2×0.72
Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A · SZSE:300832US$7.51BUS$7.10B27.8×9.8×n/a5.3×37.2%0.0×n/a
Asymchem Laboratories (Tianjin) Co., Ltd. Class A · SZSE:002821US$6.83BUS$5.89B38.5×5.3×n/a2.6×15.9%0.0×n/a
Bachem Holding AG Class B · SIX:BANBUS$6.80BUS$6.99B38.4×8.4×29.7×4.0×21.4%0.1×n/a
10x Genomics, Inc. · NASDAQ:TXGUS$6.29BUS$5.79Bn/a9.4×n/a7.5×−10.8%0.1×2.34
Anthem Biosciences Limited · NSE:ANTHEMUS$5.78BUS$5.71B87.3×25.9×62.5×16.3×30.0%0.0×n/a
Median of the othersUS$7.67BUS$7.24B35.3×6.9×62.5×3.9×13.5%0.1×2.03

Forecasts

7 strong buy · 2 buy · 4 hold · 1 strong sell · Analysts' consensus from EODHD, read Nov 22, 2026. Not 6ix's view and not investment advice.

Price target
128.82 USD · Analysts' mean
EPS, year to Sep 2027
-0.49 · 4 analysts
Revenue, year to Sep 2027
556M · 12 analysts

Team and board

Officers

OfficerRole
Emily LeproustCEO and Co-Founder of Twist
Adam LaponisChief Financial Officer
Patrick FinnPresident and Chief Operating Officer
Dennis ChoChief Legal Officer and Corporate Secretary
Angela BittingSenior Vice President, Corporate Affairs; Chief Corporate Responsibility Officer
Jimmy JinSenior Vice President of Product and Marketing
Mark BuckSenior Vice President of Operations
Nicole MorenoSenior Vice President of Sales and Support
Paula GreenSenior Vice President of Human Resources
Keith CrandellCo-Founder and Managing Director
Mike FeroChief Information Officer
Siyuan ChenChief Technology Officer

Board

DirectorRole
Nelson C. ChanChairman of the Board

Events

Calls

CallWhenStatus
Twist Bioscience (NASDAQ:TWST) Q4 2026 Earnings CallThu, Nov 12, 2026 · 8:00 AM ETReplay
Twist Bioscience (NASDAQ:TWST) Q3 2026 Earnings CallMon, Aug 03, 2026 · 8:00 AM ETReplay
Twist Bioscience (NASDAQ:TWST) Q2 2026 Earnings CallMon, May 04, 2026 · 8:00 AM ETReplay
Twist Bioscience (NASDAQ:TWST) Q1 2026 Earnings CallMon, Feb 02, 2026 · 8:00 AM ETReplay
Twist Bioscience (NASDAQ:TWST) Q4 2025 Earnings CallFri, Nov 14, 2025 · 8:00 AM ETReplay
Twist Bioscience (NASDAQ:TWST) Q3 2025 Earnings CallMon, Aug 04, 2025 · 8:00 AM ETReplay
Twist Bioscience (NASDAQ:TWST) Q2 2025 Earnings CallMon, May 05, 2025 · 8:00 AM ETReplay
Twist Bioscience (NASDAQ:TWST) Q1 2025 Earnings CallMon, Feb 03, 2025 · 8:00 AM ETReplay
Twist Bioscience (NASDAQ:TWST) Q4 2024 Earnings CallMon, Nov 18, 2024 · 8:00 PM ETReplay
Twist Bioscience (NASDAQ:TWST) Q3 2024 Earnings CallFri, Aug 02, 2024 · 8:00 AM ETReplay
All 23 calls
CallWhenStatus
Twist Bioscience (NASDAQ:TWST) Q2 2024 Earnings CallThu, May 02, 2024 · 4:30 PM ETReplay
Twist Bioscience (NASDAQ:TWST) Q1 2024 Earnings CallFri, Feb 02, 2024 · 8:00 AM ETReplay
Twist Bioscience (NASDAQ:TWST) Q4 2023 Earnings CallFri, Nov 17, 2023 · 8:00 AM ETReplay
Twist Bioscience (NASDAQ:TWST) Q3 2023 Earnings CallFri, Aug 04, 2023 · 8:00 AM ETReplay
Twist Bioscience (NASDAQ:TWST) Q2 2023 Earnings CallFri, May 05, 2023 · 8:00 AM ETReplay
Twist Bioscience (NASDAQ:TWST) Q1 2023 Earnings CallFri, Feb 03, 2023 · 8:00 AM ETReplay
Twist Bioscience (NASDAQ:TWST) Q4 2022 Earnings CallFri, Nov 18, 2022 · 8:00 AM ETReplay
Twist Bioscience (NASDAQ:TWST) Q3 2022 Earnings CallFri, Aug 05, 2022 · 8:00 AM ETReplay
Twist Bioscience (NASDAQ:TWST) Q2 2022 Earnings CallThu, May 05, 2022 · 4:30 PM ETReplay
Twist Bioscience (NASDAQ:TWST) Q1 2022 Earnings CallFri, Feb 04, 2022 · 8:00 AM ETReplay
Twist Bioscience (NASDAQ:TWST) Q4 2021 Earnings CallMon, Nov 22, 2021 · 8:00 AM ETReplay
Twist Bioscience (NASDAQ:TWST) Q3 2021 Earnings CallFri, Aug 06, 2021 · 8:00 AM ETReplay
Twist Bioscience (NASDAQ:TWST) Q2 2021 Earnings CallThu, May 06, 2021 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q4 2026Nov 12, 2026 · Before open−6.8%
Q3 2026Aug 3, 2026 · Before open+10.4%
Q2 2026May 4, 2026 · Before open−7.0%
Q1 2026Feb 2, 2026 · Before open+14.0%
Q4 2025Nov 14, 2025 · Before open−10.1%
Q3 2025Aug 4, 2025 · Before open−10.3%
Q2 2025May 5, 2025 · Before open−8.4%
Q1 2025Feb 3, 2025 · Before open+0.7%
Q4 2024Nov 18, 2024 · Before open+12.3%
Q3 2024Aug 2, 2024 · Before open−19.0%
All 20 quarters
QuarterResultsShare move
Q2 2024May 2, 2024 · After close+28.7%
Q1 2024Feb 2, 2024 · Before open+10.0%
Q4 2023Nov 17, 2023 · Before open+25.9%
Q3 2023Aug 4, 2023 · Before open+11.2%
Q2 2023May 5, 2023 · Before open−0.4%
Q1 2023Feb 3, 2023 · Before open−18.1%
Q4 2022Nov 18, 2022 · Before open−2.3%
Q3 2022Aug 5, 2022 · Before open+12.7%
Q2 2022May 5, 2022 · After close+0.8%
Q1 2022Feb 4, 2022 · Before open−2.4%

Open Events

Decks

DeckKindSlidesDate
Q4 2026 Earnings PresentationEarnings26 slidesNov 12, 2026
Q3 2026 Earnings PresentationEarnings29 slidesAug 3, 2026
William Blair 46th Annual Growth Stock Conference (May 2026)Conference36 slidesMay 2026
Q2 2026 Earnings PresentationEarnings25 slidesMay 2026
Q1 2026 Earnings PresentationEarnings24 slidesFeb 2, 2026
J.P. Morgan 2026 Healthcare ConferenceConference38 slidesJanuary 2026
Q4 2025 Earnings PresentationEarnings20 slidesNov 14, 2025
Investor Presentation (September 2025)Investor deck10 slidesSeptember 2025
Q3 2025 Earnings PresentationEarnings21 slidesAug 4, 2025
Q2 2025 Earnings PresentationEarnings23 slidesMay 5, 2025
All 16 decks
DeckKindSlidesDate
Q1 FY2024 Earnings PresentationEarnings17 slidesFebruary 2024
FY2023 Earnings PresentationEarnings18 slidesNovember 2023
Q3 FY2023 Earnings PresentationEarnings17 slidesAugust 2023
Technical Presentation (June 2022)Technical24 slidesJun 1, 2022
37th Annual JPM Healthcare Conference 2019Conference33 slidesJan 7, 2019
Investor Presentation (November 2018)Investor deck36 slidesNov 27, 2018

Open Decks

Financings

RaiseDate
Public offering of common stock
Made bigger: US$300M · US$96 a share · Goldman Sachs & Co. LLC +3
Dealers: Goldman Sachs & Co. LLC (co-lead), William Blair (co-lead), Leerink Partners (co-lead), Guggenheim Securities (co-lead)
Use of proceeds: Research and development, manufacturing capacity expansion, product offerings, working capital and general corporate purposes
Aug 5, 2026

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue459.4M376.6M313.0M245.1M203.6M132.3M90.1M54.4M25.4M10.8M
Cost of revenue218.6M185.6M179.6M155.4M119.3M80.6M61.4M47.4M32.2M24.0M
Gross profit240.8M191.0M133.3M89.7M84.2M51.7M28.7M6.96M-6.76M-13.3M
Research and development71.8M80.3M90.9M106.9M120.3M69.1M43.0M35.7M20.3M19.2M
Selling, general and administrative301.2M247.0M218.4M189.7M212.9M135.9M103.3M80.1M43.5M26.1M
Operating income-139.5M-136.3M-220.8M-217.2M-234.8M-152.7M-140.1M-108.8M-70.6M-58.5M
Depreciation and amortization26.5M24.9M31.4M29.3M16.5M9.75M6.68M6.11M5.73M5.02M
EBITDA-113.0M-111.4M-189.4M-187.8M-218.3M-143.0M-133.4M-102.7M-64.8M-53.5M
Interest expense29.0K5.00K80.0K367.0K787.0K1.29M1.31M905.0K
Income before tax-129.8M-77.0M-208.2M-203.5M-228.3M-154.0M-139.5M-107.4M-71.0M-59.0M
Income tax406.0K719.0K560.0K1.15M-10.4M-1.93M382.0K292.0K242.0K280.0K
Net income-130.2M-77.7M-208.7M-204.6M-217.9M-152.1M-139.9M-107.7M-71.2M-59.3M
Earnings per share, basic-2.08-1.30-3.60-3.60-4.04-3.15-3.57-3.92-25.51-24.49
Earnings per share, diluted-2.08-1.30-3.60-3.60-4.04-3.15-3.57-3.92-25.51-24.49

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents534.0M183.0M226.3M286.5M378.7M465.8M93.7M46.7M80.8M31.2M
Short-term investments47.9M49.4M50.1M49.9M126.3M12.0M196.3M91.4M031.0M
Receivables70.2M57.0M34.9M44.1M40.3M28.5M26.4M12.1M5.42M2.35M
Inventory46.4M28.3M24.1M32.1M39.3M31.8M12.3M7.33M6.03M1.83M
Current assets737.2M333.0M346.8M424.3M596.5M546.5M334.9M160.1M95.7M67.9M
Property, plant and equipment122.3M102.3M102.5M131.8M139.4M44.1M25.5M20.8M12.3M14.8M
Goodwill82.2M82.2M85.8M85.8M85.8M22.4M1.14M1.14M1.14M1.14M
Total assets1.12B641.9M614.3M776.4M961.4M702.1M398.9M187.0M115.8M85.7M
Accounts payable24.9M11.1M1.63M14.1M20.1M14.9M4.83M9.76M7.53M2.85M
Current liabilities125.8M91.4M71.0M73.3M90.7M63.1M36.0M30.4M18.5M9.48M
Long-term debt1.40M4.40M7.22M9.15M
Total debt137.3M85.0M94.1M01.55M4.17M7.50M9.72M218.6M
Total liabilities233.8M168.9M141.6M153.0M172.0M121.3M62.6M34.9M26.7M219.0M
Shareholders' equity888.0M473.0M472.7M623.4M789.4M580.8M336.3M152.1M-201.4M-133.4M
Shares outstanding67.8M60.6M58.9M57.6M56.5M49.5M45.1M32.9M3.21M45.2M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-41.4M-47.6M-64.1M-142.5M-124.4M-112.2M-142.3M-87.9M-66.2M-51.3M
Capital spending-47.6M-28.0M-5.08M-27.8M-101.9M-27.1M-9.87M-14.8M-3.69M-6.59M
Free cash flow-89.0M-75.6M-69.2M-170.3M-226.2M-139.3M-152.1M-102.7M-69.9M-57.9M
Cash from investing-53.1M-24.8M-3.07M50.6M-232.9M156.2M-114.7M-104.8M27.3M-9.99M
Cash from financing446.7M28.5M6.89M911.0K270.5M329.2M303.7M158.6M88.8M63.8M
Share buybacks-16.0K-3.98M-4.41M-7.75M-10.8M-2.42M161.1M91.2M65.8M
Change in cash352.2M-43.7M-60.1M-91.0M-87.1M373.1M46.8M-34.1M50.0M2.51M

Open Financials

Filings

FilingDateTypeFiled with
144 · Notice of proposed saleNov 20, 2026Other filingsSEC
144 · Notice of proposed saleNov 19, 2026Other filingsSEC
4 · Change in ownershipNov 18, 2026Insider tradeSEC
4 · Change in ownershipNov 18, 2026Insider tradeSEC
4 · Change in ownershipNov 18, 2026Insider tradeSEC
4 · Change in ownershipNov 18, 2026Insider tradeSEC
4 · Change in ownershipNov 18, 2026Insider tradeSEC
4 · Change in ownershipNov 18, 2026Insider tradeSEC
10-K · Annual reportNov 16, 2026Annual reportSEC
144 · Notice of proposed saleNov 16, 2026Other filingsSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipNov 16, 2026Insider tradeSEC
4 · Change in ownershipNov 16, 2026Insider tradeSEC
4 · Change in ownershipNov 16, 2026Insider tradeSEC
4 · Change in ownershipNov 16, 2026Insider tradeSEC
4 · Change in ownershipNov 16, 2026Insider tradeSEC
4 · Change in ownershipNov 16, 2026Insider tradeSEC
144 · Notice of proposed saleNov 16, 2026Other filingsSEC
144 · Notice of proposed saleNov 16, 2026Other filingsSEC
144 · Notice of proposed saleNov 16, 2026Other filingsSEC
144 · Notice of proposed saleNov 16, 2026Other filingsSEC
144 · Notice of proposed saleNov 16, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
8-K · Current reportNov 12, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 12, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeNov 10, 2026Big-stake noticeSEC
4 · Change in ownershipNov 5, 2026Insider tradeSEC
4 · Change in ownershipNov 5, 2026Insider tradeSEC
4 · Change in ownershipNov 5, 2026Insider tradeSEC
4 · Change in ownershipNov 5, 2026Insider tradeSEC
4 · Change in ownershipNov 5, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 5, 2026Big-stake noticeSEC
144 · Notice of proposed saleNov 3, 2026Other filingsSEC
144 · Notice of proposed saleNov 3, 2026Other filingsSEC
144 · Notice of proposed saleNov 3, 2026Other filingsSEC
144 · Notice of proposed saleNov 3, 2026Other filingsSEC
144 · Notice of proposed saleNov 3, 2026Other filingsSEC
4 · Change in ownershipOct 27, 2026Insider tradeSEC
144 · Notice of proposed saleOct 23, 2026Other filingsSEC
4 · Change in ownershipOct 13, 2026Insider tradeSEC
144 · Notice of proposed saleOct 9, 2026Other filingsSEC
4 · Change in ownershipOct 7, 2026Insider tradeSEC
144 · Notice of proposed saleOct 5, 2026Other filingsSEC
4 · Change in ownershipOct 5, 2026Insider tradeSEC
4 · Change in ownershipOct 5, 2026Insider tradeSEC
4 · Change in ownershipOct 5, 2026Insider tradeSEC
4 · Change in ownershipOct 5, 2026Insider tradeSEC
4 · Change in ownershipOct 5, 2026Insider tradeSEC
4 · Change in ownershipOct 5, 2026Insider tradeSEC
144 · Notice of proposed saleOct 2, 2026Other filingsSEC
144 · Notice of proposed saleOct 2, 2026Other filingsSEC
144 · Notice of proposed saleOct 2, 2026Other filingsSEC
144 · Notice of proposed saleOct 2, 2026Other filingsSEC
144 · Notice of proposed saleOct 2, 2026Other filingsSEC
144 · Notice of proposed saleOct 2, 2026Other filingsSEC
144 · Notice of proposed saleOct 1, 2026Other filingsSEC
4 · Change in ownershipSep 25, 2026Insider tradeSEC
144 · Notice of proposed saleSep 24, 2026Other filingsSEC
4 · Change in ownershipSep 23, 2026Insider tradeSEC
4 · Change in ownershipSep 23, 2026Insider tradeSEC
4 · Change in ownershipSep 23, 2026Insider tradeSEC
144 · Notice of proposed saleSep 21, 2026Other filingsSEC
144 · Notice of proposed saleSep 21, 2026Other filingsSEC
144 · Notice of proposed saleSep 21, 2026Other filingsSEC
4 · Change in ownershipSep 21, 2026Insider tradeSEC
144 · Notice of proposed saleSep 17, 2026Other filingsSEC
144 · Notice of proposed saleSep 17, 2026Other filingsSEC
4 · Change in ownershipSep 10, 2026Insider tradeSEC
4 · Change in ownershipSep 10, 2026Insider tradeSEC
4 · Change in ownershipSep 10, 2026Insider tradeSEC
4 · Change in ownershipSep 10, 2026Insider tradeSEC
144 · Notice of proposed saleSep 8, 2026Other filingsSEC
144 · Notice of proposed saleSep 8, 2026Other filingsSEC
144 · Notice of proposed saleSep 8, 2026Other filingsSEC
144 · Notice of proposed saleSep 8, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedSep 8, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedSep 8, 2026Big-stake noticeSEC
4 · Change in ownershipAug 27, 2026Insider tradeSEC
144 · Notice of proposed saleAug 25, 2026Other filingsSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
144 · Notice of proposed saleAug 24, 2026Other filingsSEC
4 · Change in ownershipAug 21, 2026Insider tradeSEC
144 · Notice of proposed saleAug 21, 2026Other filingsSEC
144 · Notice of proposed saleAug 21, 2026Other filingsSEC
144 · Notice of proposed saleAug 21, 2026Other filingsSEC
144 · Notice of proposed saleAug 21, 2026Other filingsSEC
144 · Notice of proposed saleAug 21, 2026Other filingsSEC
144 · Notice of proposed saleAug 21, 2026Other filingsSEC
4 · Change in ownershipAug 20, 2026Insider tradeSEC
8-K · Current reportAug 19, 2026Current reportSEC
424B7 · ProspectusAug 19, 2026Offer documentSEC
144 · Notice of proposed saleAug 19, 2026Other filingsSEC
8-K · Current reportAug 18, 2026Current reportSEC
144 · Notice of proposed saleAug 18, 2026Other filingsSEC
4 · Change in ownershipAug 14, 2026Insider tradeSEC
4 · Change in ownershipAug 14, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 14, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 13, 2026Big-stake noticeSEC
144 · Notice of proposed saleAug 12, 2026Other filingsSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
144 · Notice of proposed saleAug 12, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 11, 2026Big-stake noticeSEC
4 · Change in ownershipAug 11, 2026Insider tradeSEC
144 · Notice of proposed saleAug 10, 2026Other filingsSEC
4 · Change in ownershipAug 7, 2026Insider tradeSEC
144 · Notice of proposed saleAug 7, 2026Other filingsSEC
SCHEDULE 13G · Big-stake noticeAug 6, 2026Big-stake noticeSEC
8-K · Current reportAug 5, 2026Material contractSEC
424B5 · ProspectusAug 5, 2026Offer documentSEC
4 · Change in ownershipAug 5, 2026Insider tradeSEC
4 · Change in ownershipAug 5, 2026Insider tradeSEC
4 · Change in ownershipAug 5, 2026Insider tradeSEC
4 · Change in ownershipAug 5, 2026Insider tradeSEC
4 · Change in ownershipAug 5, 2026Insider tradeSEC
144 · Notice of proposed saleAug 5, 2026Other filingsSEC
424B5 · ProspectusAug 4, 2026Offer documentSEC
10-Q · Quarterly reportAug 3, 2026Quarterly reportSEC
144 · Notice of proposed saleAug 3, 2026Other filingsSEC
144 · Notice of proposed saleAug 3, 2026Other filingsSEC
144 · Notice of proposed saleAug 3, 2026Other filingsSEC
144 · Notice of proposed saleAug 3, 2026Other filingsSEC
144 · Notice of proposed saleAug 3, 2026Other filingsSEC
8-K · Current reportAug 3, 2026ResultsSEC
4 · Change in ownershipJul 27, 2026Insider tradeSEC
144 · Notice of proposed saleJul 23, 2026Other filingsSEC
4 · Change in ownershipJul 13, 2026Insider tradeSEC
144 · Notice of proposed saleJul 9, 2026Other filingsSEC
4 · Change in ownershipJun 26, 2026Insider tradeSEC
4 · Change in ownershipJun 26, 2026Insider tradeSEC
144 · Notice of proposed saleJun 25, 2026Other filingsSEC
4 · Change in ownershipJun 24, 2026Insider tradeSEC
4 · Change in ownershipJun 24, 2026Insider tradeSEC
4 · Change in ownershipJun 24, 2026Insider tradeSEC
144 · Notice of proposed saleJun 24, 2026Other filingsSEC
144 · Notice of proposed saleJun 22, 2026Other filingsSEC
144 · Notice of proposed saleJun 22, 2026Other filingsSEC
144 · Notice of proposed saleJun 22, 2026Other filingsSEC
S-3ASR · Registration statementJun 18, 2026Offer documentSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
144 · Notice of proposed saleJun 15, 2026Other filingsSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
144 · Notice of proposed saleJun 8, 2026Other filingsSEC
144 · Notice of proposed saleJun 8, 2026Other filingsSEC
144 · Notice of proposed saleJun 8, 2026Other filingsSEC
144 · Notice of proposed saleJun 8, 2026Other filingsSEC
144 · Notice of proposed saleJun 8, 2026Other filingsSEC
4 · Change in ownershipJun 2, 2026Insider tradeSEC
4 · Change in ownershipJun 2, 2026Insider tradeSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
144 · Notice of proposed saleMay 29, 2026Other filingsSEC
144 · Notice of proposed saleMay 29, 2026Other filingsSEC
144 · Notice of proposed saleMay 28, 2026Other filingsSEC
4 · Change in ownershipMay 28, 2026Insider tradeSEC
4 · Change in ownershipMay 28, 2026Insider tradeSEC
4 · Change in ownershipMay 28, 2026Insider tradeSEC
144 · Notice of proposed saleMay 28, 2026Other filingsSEC
144 · Notice of proposed saleMay 27, 2026Other filingsSEC
144 · Notice of proposed saleMay 26, 2026Other filingsSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
144 · Notice of proposed saleMay 26, 2026Other filingsSEC
144 · Notice of proposed saleMay 26, 2026Other filingsSEC
144 · Notice of proposed saleMay 21, 2026Other filingsSEC
144 · Notice of proposed saleMay 21, 2026Other filingsSEC
144 · Notice of proposed saleMay 21, 2026Other filingsSEC
144 · Notice of proposed saleMay 21, 2026Other filingsSEC
144 · Notice of proposed saleMay 21, 2026Other filingsSEC
144 · Notice of proposed saleMay 21, 2026Other filingsSEC
4 · Change in ownershipMay 14, 2026Insider tradeSEC
4 · Change in ownershipMay 12, 2026Insider tradeSEC
144 · Notice of proposed saleMay 12, 2026Other filingsSEC
144 · Notice of proposed saleMay 8, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 7, 2026Big-stake noticeSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
10-Q · Quarterly reportMay 4, 2026Quarterly reportSEC
144 · Notice of proposed saleMay 4, 2026Other filingsSEC
144 · Notice of proposed saleMay 4, 2026Other filingsSEC
144 · Notice of proposed saleMay 4, 2026Other filingsSEC
144 · Notice of proposed saleMay 4, 2026Other filingsSEC
144 · Notice of proposed saleMay 4, 2026Other filingsSEC
8-K · Current reportMay 4, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeApr 30, 2026Big-stake noticeSEC

This page holds 200 of 1,004 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Twist Bioscience Corporation’s releases · as of Nov 11, 2026

Common shares
68,178,692
Fully diluted
68,196,373

Fully diluted

LineSharesAs of
Common shares68,178,692Nov 11, 2026
Options and RSUs17,681

Warrants and options

Lot
RSUs · expiry not stated

Share count over time

CountShares
Nov 11, 202668,178,692

Open Cap table

Shareholders

Institutions

HolderSharesValueAs of
Fidelity9.7MUS$1.87BSep 30, 2026
T. Rowe Price6.73MUS$1.3BSep 30, 2026
Vanguard6.69MUS$1.29BSep 30, 2026
BlackRock6.39MUS$1.23BSep 30, 2026
ARK3.4MUS$657MSep 30, 2026
State Street3.02MUS$583MSep 30, 2026
Farallon Capital Management, L.L.C.2.14MUS$413MSep 30, 2026
Artisan Partners Limited Partnership2.04MUS$395MSep 30, 2026
D. E. Shaw & Co., Inc.1.83MUS$353MSep 30, 2026
Invesco1.82MUS$352MSep 30, 2026
Show 50 holders
HolderSharesValueAs of
Geode Capital1.74MUS$336MSep 30, 2026
Goldman Sachs1.71MUS$331MSep 30, 2026
William Blair Investment Management, LLC1.45MUS$281MSep 30, 2026
Bank of America1.18MUS$229MSep 30, 2026
JPMorgan1.02MUS$191MSep 30, 2026
Morgan Stanley1.02MUS$196MSep 30, 2026
Castle Hook Partners LP828KUS$160MSep 30, 2026
Stephens Investment Management Group LLC780KUS$151MSep 30, 2026
Sumitomo Mitsui Trust Group, Inc.776KUS$150MSep 30, 2026
Amova Asset Management Americas, Inc.776KUS$150MSep 30, 2026
Franklin Templeton732KUS$116MSep 30, 2026
Wellington712KUS$138MSep 30, 2026
Baillie Gifford & Co708KUS$137MSep 30, 2026
Driehaus Capital Management LLC673KUS$130MSep 30, 2026
Thrivent Financial for Lutherans638KUS$123MSep 30, 2026
Schwab638KUS$123MSep 30, 2026
Northern Trust625KUS$121MSep 30, 2026
Lord, Abbett & Co. LLC610KUS$118MSep 30, 2026
Loomis Sayles & Co L P589KUS$114MSep 30, 2026
UBS576KUS$111MSep 30, 2026
Fred Alger Management, LLC565KUS$109MSep 30, 2026
Nuveen553KUS$107MSep 30, 2026
Ameriprise546KUS$105MSep 30, 2026
Voya Investment Management LLC540KUS$104MSep 30, 2026
Millennium495KUS$95.7MSep 30, 2026
American Century489KUS$94.5MSep 30, 2026
First Light Asset Management, LLC430KUS$83.2MSep 30, 2026
BNP Paribas421KUS$81.4MSep 30, 2026
AllianceBernstein421KUS$81.4MSep 30, 2026
FIL Ltd417KUS$80.6MSep 30, 2026
Jane Street384KUS$74.2MSep 30, 2026
BNY350KUS$67.6MSep 30, 2026
Point72 Asset Management, L.P.343KUS$66.3MSep 30, 2026
Capital Group334KUS$64.6MSep 30, 2026
Russell Investments Group, Ltd.284KUS$54.9MSep 30, 2026
Allspring Global Investments Holdings, LLC256KUS$48.1MSep 30, 2026
Durable Capital Partners LP251KUS$48.5MSep 30, 2026
HSBC247KUS$48.6MSep 30, 2026
Susquehanna241KUS$46.5MSep 30, 2026
Dimensional236KUS$45.7MSep 30, 2026

This page holds 50 of 420 holders. Open Shareholders

Funds

HolderSharesValueAs of
ARK Innovation ETF2.01MUS$184MJul 31, 2026
Vanguard Total Stock Market Index Fund1.87MUS$193MJun 30, 2026
iShares Russell 2000 ETF1.59MUS$164MJun 30, 2026
State Street(R) SPDR(R) S&P(R) Biotech ETF1.47MUS$151MJun 30, 2026
Vanguard Small-Cap Index Fund1.36MUS$140MJun 30, 2026
ARK Genomic Revolution ETF1.31MUS$120MJul 31, 2026
T. Rowe Price New Horizons Fund, Inc.959KUS$98.7MJun 30, 2026
Artisan Mid Cap Fund893KUS$91.9MJun 30, 2026
Bridge Builder Small/Mid Cap Growth Fund867KUS$89.2MJun 30, 2026
Invesco Discovery Fund822KUS$55MMay 31, 2026
Show 50 holders
HolderSharesValueAs of
Vanguard Small-Cap Growth Index Fund781KUS$80.3MJun 30, 2026
Vanguard Extended Market Index Fund715KUS$73.5MJun 30, 2026
Fidelity Small Cap Index Fund679KUS$62.2MJul 31, 2026
Vanguard Explorer Fund605KUS$55.3MJul 31, 2026
iShares Russell 2000 Growth ETF573KUS$59MJun 30, 2026
T. Rowe Price Health Sciences Fund, Inc.555KUS$57.1MJun 30, 2026
Artisan Small Cap Fund517KUS$53.2MJun 30, 2026
T. Rowe Price Global Stock Fund462KUS$42.3MJul 31, 2026
Fidelity Small Cap Growth Fund448KUS$41MJul 31, 2026
Thrivent Small Cap Stock Fund443KUS$40.5MJul 31, 2026
iShares Biotechnology ETF422KUS$43.4MJun 30, 2026
Fidelity Stock Selector Small Cap Fund384KUS$35.1MJul 31, 2026
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund367KUS$37.7MJun 30, 2026
Loomis Sayles Small Cap Growth Fund360KUS$37.1MJun 30, 2026
Columbia Small Cap Growth Fund354KUS$23.7MMay 31, 2026
Small Cap Growth Fund319KUS$29.2MJul 31, 2026
Fidelity Extended Market Index Fund317KUS$21.2MMay 31, 2026
Vanguard Russell 2000 Index Fund311KUS$20.8MMay 31, 2026
Schwab U.S. Small-Cap ETF294KUS$19.7MMay 31, 2026
Invesco Main Street Small Cap Fund288KUS$29.6MJun 30, 2026
State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF278KUS$28.7MJun 30, 2026
Thrivent Small Cap Stock Portfolio267KUS$27.4MJun 30, 2026
Voya Global Insights Portfolio265KUS$27.3MJun 30, 2026
Select Medical Technology and Devices Portfolio250KUS$16.7MMay 31, 2026
Select Biotechnology Portfolio239KUS$16MMay 31, 2026
Fidelity Small Cap Growth K6 Fund228KUS$20.9MJul 31, 2026
Alger Small Cap Focus Fund222KUS$20.4MJul 31, 2026
Fidelity Series Small Cap Opportunities Fund220KUS$20.2MJul 31, 2026
Driehaus Small Cap Growth Fund216KUS$22.3MJun 30, 2026
Lord Abbett Bond Debenture Fund Inc205KUS$21MJun 30, 2026
William Blair Small-Mid Cap Growth Fund203KUS$20.9MJun 30, 2026
Nuveen Quant Small Cap Equity Fund197KUS$18MJul 31, 2026
William Blair Small Cap Growth Fund192KUS$19.8MJun 30, 2026
Vanguard Health Care Index Fund181KUS$12.1MMay 31, 2026
T. Rowe Price Small-Cap Stock Fund, Inc.177KUS$18.3MJun 30, 2026
Invesco V.I. Main Street Small Cap Fund160KUS$16.5MJun 30, 2026
Schwab Small-Cap Index Fund151KUS$13.8MJul 31, 2026
Fidelity Enhanced Small Cap Core ETF147KUS$15.1MJun 30, 2026
Alger Mid Cap Focus Fund142KUS$13MJul 31, 2026
Thrivent Small-Mid Cap Equity ETF141KUS$14.5MJun 30, 2026

This page holds 50 of 345 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Laponis Adam
Officer: Chief Financial Officer
Sale6,359USD 103.69US$659KNov 16, 2026
Werner Robert F.
Officer: Chief Accounting Officer
Sale1,637USD 103.69US$170KNov 16, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale19,045USD 103.69US$1.97MNov 16, 2026
Green Paula
Officer: SVP of Human Resources
Sale4,281USD 103.69US$444KNov 16, 2026
Finn Patrick John
Officer: President and COO
Sale12,752USD 103.69US$1.32MNov 16, 2026
Cho Dennis
Officer: See Remarks
Sale5,427USD 103.69US$563KNov 16, 2026
Green Paula
Officer: SVP of Human Resources
Sale20,429USD 0.00Nov 12, 2026
Werner Robert F.
Officer: Chief Accounting Officer
Sale148USD 135.40US$20,039Nov 3, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale4,573USD 135.40US$619KNov 3, 2026
Green Paula
Officer: SVP of Human Resources
Sale1,007USD 135.40US$136KNov 3, 2026
Show 50 trades
TradeTradeSharesPriceValueDate
Finn Patrick John
Officer: President and COO
Sale2,565USD 135.40US$347KNov 3, 2026
Cho Dennis
Officer: See Remarks
Sale949USD 135.40US$128KNov 3, 2026
Finn Patrick John
Officer: President and COO
Sale2,245USD 134.59US$302KOct 23, 2026
Laponis Adam
Officer: Chief Financial Officer
Sale2,462USD 156.30US$385KOct 9, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale1,840USD 200.44US$369KOct 5, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale481USD 201.26US$96,804Oct 5, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale1,017USD 202.32US$206KOct 5, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale432USD 203.61US$87,958Oct 5, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale290USD 204.80US$59,392Oct 5, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale297USD 205.78US$61,116Oct 5, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale146USD 206.84US$30,199Oct 5, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale45USD 207.46US$9,336Oct 5, 2026
Cho Dennis
Officer: See Remarks
Sale9,514USD 188.88US$1.8MOct 2, 2026
Finn Patrick John
Officer: President and COO
Sale25,714USD 188.88US$4.86MOct 2, 2026
Green Paula
Officer: SVP of Human Resources
Sale10,088USD 188.88US$1.91MOct 2, 2026
Laponis Adam
Officer: Chief Financial Officer
Sale8,057USD 188.88US$1.52MOct 2, 2026
Werner Robert F.
Officer: Chief Accounting Officer
Sale1,482USD 188.88US$280KOct 2, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale45,736USD 188.88US$8.64MOct 2, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale655USD 200.00US$131KOct 1, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale2,485USD 175.23US$435KSep 24, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale945USD 176.39US$167KSep 24, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale164USD 177.17US$29,056Sep 24, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale330USD 178.67US$58,961Sep 24, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale143USD 179.93US$25,730Sep 24, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale515USD 180.39US$92,901Sep 24, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale21USD 181.45US$3,810Sep 24, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale16USD 182.50US$2,920Sep 24, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale501USD 183.76US$92,064Sep 24, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale83USD 184.60US$15,322Sep 24, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale1,687USD 165.49US$279KSep 21, 2026
Green Paula
Officer: SVP of Human Resources
Sale294USD 165.49US$48,654Sep 21, 2026
Cho Dennis
Officer: See Remarks
Sale348USD 165.49US$57,591Sep 21, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale2,440USD 151.46US$370KSep 17, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale6,644USD 152.21US$1.01MSep 17, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale3,399USD 153.40US$521KSep 17, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale4,175USD 154.17US$644KSep 17, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale13,378USD 155.46US$2.08MSep 17, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale9,097USD 156.47US$1.42MSep 17, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale32,260USD 157.49US$5.08MSep 17, 2026
Leproust Emily M.
Director, Officer: Chief Executive Officer
Sale232,173USD 158.09US$36.7MSep 17, 2026

This page holds 50 of 137 trades. Open Shareholders

Big stakes

StakeStakeSharesDateFiling
FMR LLC14.40%9.54MSep 30, 2026Schedule 13G
T. Rowe Price Associates Inc9.20%6.08MSep 30, 2026Schedule 13G
BlackRock, Inc.8.30%4.93MMar 31, 2025Schedule 13G
ARK Investment Management LLC5.11%3.39MAug 31, 2026Schedule 13G
Vanguard Capital Management LLC5.05%3.1MMar 31, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Nelson C. Chan
Other companies: GCT Semiconductor Holding, Inc. (Director · Since at least Mar 26, 2024); Deckers Outdoor Corporation (Director · Since at least Dec 16, 2014); Synaptics Incorporated (Director · Since at least Feb 20, 2007); Socket Mobile, Inc. (Director · Oct 3, 2016 – May 22, 2019 · Past); Adesto Technologies Corporation (Director · Oct 26, 2015 – Jun 29, 2020 · Past); Outerwall Inc (Director · Jul 5, 2011 – Sep 23, 2016 · Past); Affymetrix Inc (Director · Mar 8, 2010 – Mar 31, 2016 · Past); Silicon Laboratories, Inc. (Director · Sep 10, 2007 – Apr 23, 2009 · Past); Sandisk Corporation (EVP & GM, Consumer Hndst Bus · Feb 1, 2006 – Nov 14, 2006 · Past)
Director · Since at least May 20, 2019
Keith Crandell
Other companies: Kardigan, Inc. (Director · Since at least Jun 22, 2026); Metsera, Inc. (Director · Since at least Nov 13, 2025); 908 Devices Inc. (Director · Since at least Dec 17, 2020); Da32 Life Science Tech Acquisition Corp (Director · Jul 27, 2021 – Jul 28, 2023 · Past); Quanterix Corporation (Director · Dec 6, 2017 – Apr 3, 2023 · Past); Adesto Technologies Corporation (Director · Oct 26, 2015 – Jun 4, 2019 · Past); Celebrate Express Inc (Director · Oct 19, 2006 – Aug 29, 2008 · Past)
Co-Founder and Managing Director · Since at least Oct 30, 2018
Bob Ragusa
Other companies: Alamar Biosciences, Inc. (Director · Since at least Sep 1, 2026); GRAIL, Inc. (Chief Executive Officer, Director · Since at least Jun 3, 2024); Illumina, Inc. (SVP, Global Quality & Ops · Jan 1, 2019 – Feb 17, 2021 · Past); Accuray Incorporated (EVP Engineering & Global · Jan 1, 2013 – Oct 31, 2013 · Past)
Director · Since at least Oct 30, 2018
Nicolas M. Barthelemy
Other companies: Repligen Corporation (Director · Since at least May 11, 2016); 908 Devices Inc. (Director · Dec 17, 2020 – Jun 15, 2022 · Past); Standard BioTools Inc. (Director · Mar 23, 2017 – Apr 1, 2022 · Past)
Director · Oct 24, 2019 – Nov 21, 2022 · Past
Katryn Blake
Other companies: TripAdvisor, Inc. (Director · Since at least Jun 8, 2021); Ally Financial Inc. (Director · Oct 9, 2020 – Jan 7, 2022 · Past)
Director · Since at least Aug 5, 2025
Adam Laponis
Other companies: Eargo, Inc. (Chief Financial Officer · Oct 15, 2020 – Nov 20, 2023 · Past)
Chief Financial Officer · Since at least Jan 8, 2024
Emily Leproust
Other companies: GeneDx Holdings Corp. (Director · Since at least Jun 18, 2026)
Chief Executive Officer, Director · Since at least Apr 21, 2026
Fred B Craves
Other companies: Madrigal Pharmaceuticals, Inc. (Director · Jun 11, 2018 – Mar 12, 2025 · Past)
Director · Oct 30, 2018 – Jul 23, 2019 · Past
Kevin Bruce Yankton
Other companies: Varex Imaging Corporation (Chief Accounting Officer · Jan 27, 2017 – Feb 18, 2021 · Past)
Chief Accounting Officer · Aug 5, 2021 – May 17, 2023 · Past
Michael Sullivan
Other companies: Illumina, Inc. (Chief Commercial Officer · Since at least Jul 9, 2026)
Corporate Communications Manager · Oct 6, 2025 – Nov 4, 2026 · Past
All 28 people
PersonSeat
Robert B. Chess
Other companies: Nektar Therapeutics (Chairman of the Board, Nektar Therapeutics · Since at least Feb 24, 2006)
Director · Since at least Oct 30, 2018
Angela BittingSenior Vice President, Corporate Affairs; Chief Corporate Responsibility Officer · Since at least May 4, 2026
Bob RagusaUntil Oct 7, 2026 · Past
Dennis ChoChief Legal Officer and Corporate Secretary · Since at least May 4, 2026
Jimmy JinSenior Vice President of Product and Marketing · Since at least Nov 4, 2026
Mark BuckSenior Vice President of Operations · Since at least Nov 5, 2026
Mark DanielsSee Remarks · Oct 24, 2020 – Apr 1, 2021 · Past
Martin KunzSVP, Operations · Feb 4, 2019 – Oct 24, 2019 · Past
Melissa StarovasnikDirector · Since at least Apr 1, 2026
Mike FeroChief Information Officer · Since at least Nov 4, 2026
Nicole MorenoSenior Vice President of Sales and Support · Since at least Nov 5, 2026
Patrick FinnPresident and Chief Operating Officer · Since at least Sep 25, 2019
Paula GreenSVP of Human Resources · Since at least May 4, 2026
Robert F WernerChief Accounting Officer · Since at least Nov 2, 2023
Siyuan ChenChief Technology Officer · Since at least Nov 5, 2026
Trynka Shineman BlakeAug 6, 2025 – Oct 7, 2026 · Past
William BanyaiSee Remark · Oct 30, 2018 – May 3, 2024 · Past
Xiaoying MaiDirector · Oct 30, 2018 – Feb 6, 2024 · Past

Open People

Log in to ask 6ix AI your own questions about Twist Bioscience Corporation.